Still Living Better through Chemistry: An Update on Caloric Restriction and Caloric Restriction Mimetics as Tools to Promote Health and Lifespan.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing mechanistic research on caloric restriction and mimetics without original experimental data or systematic search methodology.
PubMed 33287232 · doi:10.3390/ijms21239220
What was done
This paper provides a narrative review updating current research on caloric restriction (CR), dietary restriction of specific elements (such as individual amino acids), and pharmacological CR mimetics—including rapamycin and its derivatives, metformin, and dietary nutraceuticals. It summarizes the mechanisms by which these strategies influence genome function to address age-related pathologies.
What was found
The abstract reports no numerical data or statistical findings. It notes qualitatively that caloric restriction extends healthspan and lifespan across organisms, that compounds such as rapamycin, metformin, and nutraceuticals induce CR-like states in laboratory models, and that the extent to which these diverse strategies mechanistically overlap remains unclear.
Why it matters
Because long-term dietary restriction is difficult for human populations to sustain, identifying pharmacological mimetics that trigger equivalent longevity pathways offers potential therapeutic strategies for age-related disease.
Limits
As a narrative review, the paper provides no original empirical data or systematic synthesis. The abstract presents no human clinical trial outcomes, quantitative effect sizes, dosing parameters, or safety profiles.
Cited by
- supports Rapamycin targets mTOR and broadly mimics the biological effects of fasting.